Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Clin Infect Dis. 2009 Jul 1;49(1):148–154. doi: 10.1086/599610

Table 2.

Results of multivariable regression model of predictors of conversion from isolated anti-HBc status to the presence of both anti-HBc and anti-HBs

Group, variable Odds ratio (95% CI) P
All subjects in bordered area of figure 1 (n = 292)
  Time since baseline, years 1.06 (0.96–1.18) .26
  HCV RNA–positive status 0.25 (0.14–0.46) <.001
HIV-infected subjects in bordered area of figure 1 (n = 255)
  HAART at >50% of visits 2.11 (1.16–3.82) .01

NOTE. Anti-HBc, antibody to hepatitis B core antigen; anti-HBs, antibody to hepatitis B surface antigen; CI, confidence interval; HAART, highly active antiretroviral therapy; HCV, hepatitis C virus; HIV, human immunodeficiency virus.